Skip to content
Home » NEWS & EVENTS

NEWS & EVENTS

  • All
  • Access to prescription medicines
  • Advocacy & Policy Momentum
  • AIM-SAFE
  • BPDCN
  • CPE Projects
  • Cross border clinical trials
  • EASYGEN
  • EOSC4Cancer
  • ESR1 Mutation
  • European Health Data Space
  • Events
  • GLIOMATCH
  • Health Technology Assessment
  • IMAGIO
  • ImmuneT-ME
  • INSPIRE
  • INTERCEPTOR
  • iNTERVENE
  • iNTERVENE 2025
  • Members
  • myC
  • News
  • OASIS
  • OncoProTools
  • OPTIMIZE
  • Patients Information
  • PERIFORMANCE
  • Pharmaceutical Legislation
  • Policy
  • PREVENT
  • Projects News
  • Prostate Cancer & Precision Oncology
  • Publications
  • Qualitop
  • SALVOVAR
  • SEISMIC
  • THERMOBREAST
  • Treatment Optimisation
  • Unmet Medical Needs
  • Vacancies
  • VOICE PM

CPE Launches New Patient Survey on Metastatic Prostate Cancer Tests, Scans and Treatments

Cancer Patients Europe (CPE) is proud to announce the launch of a new patient survey aimed at people living with metastatic prostate cancer, as… Read More

SEISMIC Consortium Meeting Brings Partners Together in Barcelona

On 24–25 September, CPE joined partners from across Europe for the SEISMIC consortium meeting in Barcelona, hosted by Hospital Clínic de Barcelona. SEISMIC is… Read More

CPE at the World Cancer Congress 2026

From 24–26 September 2026, CPE joined the World Cancer Congress 2026 in Hong Kong, organised by the Union for International Cancer Control (UICC) and… Read More

CPE Launches Policy Statement on Most Favoured Nation Drug Pricing

CPE has published its Policy Statement "Most Favoured Nation Drug Pricing: Ensuring Patient Access to Innovation in Europe" and is now inviting organisations across Europe to… Read More

PERIFORMANCE Partners Met in Vienna to Advance the Project’s Work

On 9–10 September 2026, CPE joined partners of the PERIFORMANCE project in Vienna for the in-person project’s Annual Consortium Meeting. PERIFORMANCE is a Horizon… Read More

Building Better Clinical Trials Together: Key Takeaways from the SALVOVAR Stakeholder Dialogue

Too many anti-cancer drugs reach patients without clear answers on the right dose, the right duration, or the right combination. The result: avoidable side… Read More

SALVOVAR Partners Met in Brussels to Advance the Project’s Next Phase

On 10–11 September 2026, partners of the SALVOVAR project met in Brussels for their annual project meeting, hosted by CPE. SALVOVAR is a European… Read More

Save the Date: Building Better Clinical Trials Together. A Stakeholder Dialogue on Pragmatic Clinical Trials in Europe

CPE, within the SALVOVAR project, is pleased to announce a stakeholder workshop, Building Better Clinical Trials Together: A Stakeholder Dialogue on Pragmatic Trials in Europe, to… Read More

My Cancer Navigator: Free, Personalised Support to Help You Navigate Cancer

Receiving a cancer diagnosis can be overwhelming. Alongside the emotional impact, patients and their loved ones are often faced with complex and overwhelming medical… Read More

Vacancy – CPE Research and Patient Engagement Intern

The Organisation Cancer Patients Europe (CPE) is a pan-European and pan-cancer type association based in Brussels. It was established to represent and empower the… Read More

Vacancy – CPE Communications Intern

The Organisation Cancer Patients Europe (CPE) is a pan-European and pan-cancer type association based in Brussels. It was established to represent and empower the… Read More

Vacancy – CPE Project Finance Officer

The Organisation Cancer Patients Europe (CPE) is a pan-European and pan-cancer type association based in Brussels. It was established to represent and empower the… Read More

CPE Co-Authors Joint Stakeholder Statement on the First Joint Clinical Assessment Report

CPE has joined a coalition focused on the advanced therapies and rare diseases, including patient organisations, clinicians, medical societies, academic centres and therapy developers, in endorsing a joint… Read More

CPE and myTomorrows: Free Support to Explore Clinical Trial Options

Wondering whether a clinical trial could be an option for you or someone you care for? Clinical trial opportunities can be difficult to navigate — eligibility… Read More

Why Shared Decision-Making Matters for Cancer Patients

Every cancer diagnosis comes with difficult treatment decisions. While healthcare professionals provide medical expertise, patients bring their own experiences, values and priorities. Shared Decision-Making (SDM) brings… Read More

CPE contributes to the next phase of the PREVENT project at the 5th Plenary Meeting in Barcelona

On 7-8 July 2026, CPE joined partners from across Europe at the 5th PREVENT Plenary Meeting in Barcelona to review the project progress, share results from… Read More

VOICE PM Networking Event Strengthened Collaboration on Meaningful Patient Involvement in Translational Personalised Medicine Research

On 24–25 June 2026, Cancer Patients Europe (CPE) welcomed researchers, patient advocates, clinicians, policymakers, regulatory experts, and project representatives to Brussels for the VOICE… Read More

Putting Patients at the Heart of Research: CPE Leads Seminar for Clinicians and Researchers

On 15 June 2026, our Research and Patient Engagement Director, Juan-José Ventura, led Seminar 7: Patient Engagement in Research — An Introduction for Clinicians &… Read More

CPE joins call for France to make antimicrobial resistance a G7 priority

As G7 leaders gathered in Evian from 15 to 17 June, CPE joined around 60 experts — clinicians, researchers, patient organisations and industry partners — in an open… Read More

DynamiCity Project Kicks Off to Promote Active Mobility for Cancer Prevention and Healthier Cities

On 3–4 June 2026, CPE attended the DynamiCity project kick-off meeting in L'Hospitalet de Llobregat (Barcelona), Spain, marking the start of a collaborative effort under the Horizon Europe programme. Bringing together… Read More

Cancer Patients Europe Joined AIM‑SAFE Kickoff Meeting in Copenhagen

CPE participated in the AIM‑SAFE project’s kickoff meeting, held from 1 to 3 June in Copenhagen, bringing together partners from across Europe. The AIM‑SAFE project, funded by… Read More

Momentum 2026 – Accelerating Europe’s action on cancer

Momentum is a European high-level cancer conference organised by the Swedish Cancer Society and endorsed by us at Cancer Patients Europe, together with the… Read More

Join the VOICE PM Networking Event on Meaningful Patient Involvement in Translational Personalised Medicine Research

Cancer Patients Europe (CPE) is pleased to invite researchers, clinicians, patient representatives, policymakers, regulatory bodies, and industry stakeholders, to participate in the VOICE PM… Read More

The Price of Access: What MFN Drug Pricing Could Mean for Cancer Patients in Europe

On 8 May 2026, CPE hosted the webinar "The Price of Access: MFN Drug Pricing – What Could It Mean for Patient Access in Europe?" as part… Read More

Europe at a Crossroads. Progress Made. Leadership at Risk. A Call to Act.

Europe has come a long way in the fight against cancer. More people are surviving, more treatments are reaching patients, and for the first time in history,… Read More

CPE at ESTRO 2026: Championing Patient-Centred Innovation in Radiation Oncology

On 15-19 May 2026 CPE joined the Annual ESTRO Congress - “Innovating Radiation Oncology, Together” in Stockholm, Sweden.    ESTRO is the Europe's leading radiation oncology event, showcasing and learn from… Read More

INSPIRE Final Event & Workshop: The Future of Palliative Rehabilitation in Cancer Care

On 16 May 2026, CPE, together with the European Association for Palliative Care (EAPC) and Hlas Onkologických Pacientů, organised the INSPIRE Final Event, “Rehabilitation in Cancer Care – An Integral… Read More

CPE Brings the Patient Voice to the JANE‑2 Network of Expertise on Personalised Prevention 

On 11-12 May 2026, CPE CEO Antonella Cardone took part in the Network of Expertise in Personalised Prevention (WP8) in‑person meeting held in São Miguel, Azores. The meeting is part of JANE-2, an EU Joint… Read More

CPE at the IMAGIO Consortium Meeting: Advancing Communication and Patient Engagement in Cancer Innovation

On 19–20 May 2026, CPE proudly took part in the annual IMAGIO Consortium Meeting held in Cologne. IMAGIO is a public-private partnership project funded under the… Read More

SEISMIC Online Workshop: Strengthening the Voice of Patients in Research

On 30 April 2026, CPE organised the Online Workshop on Patient Advocacy as part of the SEISMIC project. The workshop brought together SEISMIC consortium partners, clinicians, and researchers to strengthen collaboration for better… Read More

Cancer Patients Europe joins the EASYGEN Consortium to advance access to CAR-T therapies

CPE is proud to join the EASYGEN Consortium, a European Union-funded research initiative bringing together hospitals, universities, companies and patient organisations to rethink how CAR-T cell therapies are… Read More

CPE at the SANOFI Co-Lab Annual Meeting 2026

On 22–23 April 2026 in Paris, Antonella Cardone, CPE CEO, participated in the Sanofi Co-Lab Annual Meeting. The Sanofi Co-Lab Annual Meeting brings together representatives from patient organisations worldwide… Read More

CPE at the CSO Annual Leadership Meeting 

On 14-15 April 2026, Antonella Cardone, CPE CEO, participated in the Annual Leadership Meeting by Common Sense Oncology in Montreal, Canada. The meeting gathered global leaders from across oncology,… Read More

OPTIMIZE Project Kicks Off to Improve Treatment and Preserve Quality of Patients’ Life in Laryngeal Cancer

On 20 April 2026, the OPTIMIZE project partners came together at IRCCS Humanitas Research Hospital in Milan for the kick-off meeting, marking the start of a collaborative effort under the European… Read More

CPE at the EAA Spring Convention: Co-Shaping the Future of the EU HTA Regulation

On 16–17 April 2026, CPE co-hosted the European Access Academy (EAA) Spring Convention in Brussels, alongside European Hematology Association (EHA). Centred on the implementation of the #EUHTA Regulation, the two-day… Read More

Cured. Not Forgotten. Not Punished. Our Call for Binding Protection for Cancer Survivors.

Beating cancer is one of the hardest things a person can do, yet for too many survivors across Europe, the fight does not end with the last… Read More

The Results Are In: Cancer Patients See a Cure Within Reach, But Call for a Better Care Experience

Cancer care is being transformed by new therapies, earlier diagnostics, and personalised medicine; yet for millions of patients across Europe, this progress is not always felt where… Read More

INSPIRE Online Workshop: “Strengthening Patient Participation in Palliative Rehabilitation Research”

On 30 March 2026, CPE, in collaboration with European Association for Palliative Care (EAPC) and with the support of the INSPIRE Consortium, organised the INSPIRE Online Workshop “Strengthening Patient… Read More

A Step Forward for Liver Cancer Treatment: Insights from IMAGIO

CPE is pleased to share updates from IMAGIO on the RADIANT study (Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose), which explores innovative strategies to enhance… Read More

CPE at the 41st Annual European Association of Urology (EAU) Conference

On 13-16 March 2026, CPE Vice-Chair of the Board Jacqueline Daly, and CPE Treasurer James Caldwell attended the 41st Annual European Association of Urology (EAU) Conference in London. The EAU Congress is one of the… Read More

ImmuneT-ME Consortium Meets in Cologne marking Key Project Milestone

The ImmuneT-ME consortium gathered for its first in-person meeting on 25 and 26 February 2026 at Uniklinik Köln in Cologne. The meeting brought together partners from across Europe… Read More

OASIS General Assembly and Patient Advisory Board (PAB)

On 16 - 17 February 2026, CPE participated alongside project partners in the OASIS General Assembly, combined with a meeting of the Patient Advisory Board (PAB). Held at the Faculté de… Read More

CPE at the EFPIA Precision Oncology Platform: Closing the Awareness Gap in Metastatic Breast Cancer

On 5 March 2026, CPE participated in the EFPIA Precision Oncology Platform Session in Toledo, Spain. The session, titled “From Evidence to Action: Closing the Awareness Gap in Precision Oncology”, focused… Read More

KELIM: A Smarter Way to Understand Chemotherapy Response in Ovarian Cancer

For patients with ovarian cancer, knowing whether chemotherapy is working is one of the most important questions in the treatment journey. A clinical tool… Read More

Combating AMR in Oncology: A Strategic Imperative for EU Health Policy

On 4 March 2026, CPE held the high-level event “Safeguarding Cancer Care in Europe: Addressing Antimicrobial Resistance (AMR) to Protect Vulnerable Patients” at the European Parliament in… Read More

Register now for the INSPIRE Online Workshop “Strengthening Patient Participation in Palliative Rehabilitation Research”

CPE, in collaboration with European Association for Palliative Care (EAPC) and with the support of the INSPIRE Consortium, is organising the INSPIRE Rehabilitative Palliative Care Online Workshop “Strengthening Patient Participation in Palliative Rehabilitation… Read More

CPE at the World Evidence, Pricing and Access Congress: Advancing the Patient Voice in Rare Disease Access

On 3 March 2026, CPE was at the World Evidence, Pricing and Access (EPA) Congress 2026 in Amsterdam, addressing the systemic barriers facing rare cancer patients across… Read More

Cancer Patients Europe Responds to European Court of Auditors’ Report on Europe’s Beating Cancer Plan

CPE welcomes the publication of the European Court of Auditors' (ECA) report "Europe's Beating Cancer Plan: A wide-ranging plan facing an uncertain future", released on 19 February… Read More

CPE Joins the SEISMIC Consortium to Transform Minimally Invasive Brain Treatments

CPE is part of the SEISMIC Consortium project, a major European research initiative funded by the Innovative Health Initiative. The SEISMIC kicked off on 28 and 29 January at the Philips Healthcare Academy, on… Read More

Improving Access to Precision Oncology: Key Takeaways from the Breast Cancer Event in Madrid

On February 11, 2026, CPE, together with Federación Española de Cáncer de Mama (FECMA) and Asociación Española Cáncer de Mama Metastásico (AECMM), hosted the event “Accessibility to new therapies and diagnostic tools for Breast Cancer patients in Spain” at the… Read More

Nutrition in Cancer Care: Closing the Gap Between Awareness and Action

On 3 February, on the eve of World Cancer Day, CPE hosted the high-level policy event “Nutrition in Cancer Care: Closing the Gap Between Awareness and Action” at the European Parliament… Read More

CPE at ESGO High-Level Policy Event: Addressing Women’s Health Unmet Needs Through Collaboration and Excellence

On 28 January 2026, CPE participated in the European Society of Gynaecological Oncology (ESGO) high-level policy event at the European Parliament, “Addressing women’s health unmet needs through collaboration and… Read More

CPE at the Cencora Webinar: Navigating Global Policy Shifts Through the Patient Lens

On 22 January 2026, CPE took part in the Cencora webinar “Navigating global policy shifts: Implications for Europe’s pharmaceutical pricing, market access, and HTA landscape” to discuss how global… Read More

CPE at the EPF Webinar: One Year of HTA Regulation Implementation Through the Patient Lens

On 13 January 2026, CPE took part in the European Patients’ Forum (EPF) webinar “One Year of HTA Regulation Implementation – What Has Changed for Patients?”, marking the first… Read More

Treating Cancer 2025: Role of AI to Tackle Cancer Inequalities in Europe

On 17 December 2025, CPE took part in Treating Cancer 2025: from the EU’s Commitment to Action in Italy against Cancer Inequalities, a high-level event held… Read More

Register now for INSPIRE Final Event: Rehabilitation as an Integral Part of Contemporary Palliative Care

Cancer Patients Europe (CPE), in collaboration with Cancer Patients Voice with support from European Association for Palliative Care, is organising the INSPIRE Final Event on Saturday 16 May 2026, from… Read More

Shaping the Future of Cancer Care: CPE at the Seventh European Cancer Forum

On 4 December 2025, CPE joined key stakeholders at the Seventh European Cancer Forum in Brussels, under the theme “Innovation, Security and Sustainability: Shaping the Future of Cancer… Read More

Driving Implementation of Europe’s Beating Cancer Plan Through Accountability and Patient-Centred Policy

On 1 December 2025, CPE co-organised with the EFPIA Oncology Platform the Europe’s Beating Cancer Plan (EBCP) / National Cancer Control Programmes (NCCP) Implementation Study Webinar:… Read More

CPE at the European Parliament: Integrating Patients’ Perspectives in EU Health Policy

On 3 December 2025, CPE participated in the event “From Risk to Action: Preventing Liver Health Crises Through NCD Literacy and Care,” organized by The Parliament… Read More

Investing in Health for Europe’s Future: CPE at the 2025 European Health Summit

On 3 December 2025, CPE took part in the European Health Summit 2025 in Brussels, under the theme “NextGen Simplified: Rethinking Health for Tomorrow.” The Summit explored how… Read More

Ethical Considerations in AI Mortality Risk Prediction: Insights from INTERVENE

Artificial intelligence (AI) is increasingly being used to predict health outcomes, offering new possibilities for early intervention and personalised care. A recent study from Finland introduces… Read More

CPE at the World Cancer Leaders’ Summit 2025: Placing Patients at the Heart of Global Cancer Policy

From 18–20 November 2025, CPE participated in the UICC’s World Cancer Leaders’ Summit (WCLS) in Melbourne, Australia, hosted by Cancer Council Victoria. Under the theme “Bridging Divides, Building… Read More

CPE at the EHA Workshop: Ensuring Meaningful Patient Involvement in Joint European Clinical Assessments

On 21 November 2025, CPE participated in the European Huntington Association (EHA) Workshop “Access to Future Therapies – How Can We Ensure Patient Involvement in HTA Procedures… Read More

CPE at ISPOR Europe 2025: Embedding the Patient Voice in Health Technology Assessment and Research

From 9–12 November 2025, CPE participated in ISPOR Europe 2025, held in Glasgow, Scotland. Under the theme “Powering Value and Access Through Patient-Centered Collaboration,” the conference explored how to strengthen partnerships across the… Read More

CPE at the EU Life Science Strategy High-Level Roundtable: Bridging Innovation and Access for Patients Across Europe

On 7 November 2025, CPE took part in the high-level roundtable “From Visions to Impact: Bringing the EU Life Science Strategy to Life,” hosted by Johnson & Johnson Innovative Medicine and… Read More

CPE at the EAA Fall Convention: Advancing Patient-Centred Evaluation in the EU HTA Framework

On 6–7 November 2025, CPE participated in the European Access Academy (EAA) Fall Convention, held at Université Paris Cité. The high-level event, titled “EU HTA – Procedural Insights & First Learnings”, focused… Read More

CPE at the EUHPP Live Webinar: Strengthening Patient Engagement in Cancer Research under the EU Cancer Mission

On 3 November 2025, CPE participated in the EU Health Policy Platform (EUHPP) Live Webinar on the Cancer Mission: Diagnosis and Treatment (Refractory Cancers and Diagnostics). Organised by… Read More

Building Equity, Access, and Sustainability in Cancer Care: CPE’s High-Level Policy Event at the European Parliament 

On 4 November 2025, CPE hosted the high-level policy event “Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy” at the European Parliament in Brussels.… Read More

Investing in Care: CPE Co-Hosts Strategic Dialogue on Nurse Retention and Sustainable Health Systems

On 4 November 2025, CPE co-hosted the high-level European Health Workforce and Care Strategy Forum in Brussels, organised by the European Specialist Nursing Organisation (ESNO), the European Union of Private Hospitals (UEHP), and European Care… Read More

CPE at BEHEALTH 2025: Advancing Europe’s Beating Cancer Plan and Tackling Inequalities in Care

On 23 October 2025, CPE spoke at BEHEALTH 2025 in the panel “Europe’s Beating Cancer Plan: Strategies and Implementation”, part of the event’s focus on Digital Transformation in… Read More

CPE at the World Orphan Drug Congress Europe 2025: Ensuring Meaningful Patient Involvement in the JCA for ATMPs

On 28 October 2025, CPE took part in the World Orphan Drug Congress Europe 2025 at the RAI Convention Centre in Amsterdam. The panel discussion, “How Will the JCA for… Read More

CPE at the Alira Health Webinar: Unlocking Patient Insights Through Meaningful Collaboration

On October 22, 2025, CPE joined global Patient Advocacy Group (PAG) leaders for the interactive webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration,” organised by Alira Health. The session… Read More

CPE at the EP PerMed Symposium: Accelerating Personalised Medicine Implementation Through Patient Advocacy and HTA

On 21 October 2025, CPE participated in the 1st EP PerMed Expert Symposium on Personalised Medicine Implementation, held in Bilbao, Spain. The event, organised under the Horizon Europe EP PerMed initiative,… Read More

Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients

On Tuesday, 14 October 2025, CPE and Pancreatic Cancer Europe (PCE) hosted a webinar on The Role of EU HTA in National Healthcare: Bridging Policy and Patient… Read More

Ensuring Equity and Patient Involvement: Key Takeaways from the HTA Event in Spain

On October 10, 2025, CPE, together with the Asociación Española Contra el Cáncer (AECC) and the Fundació HiTT, hosted the event “Access to Medicines for Cancer Patients: Spain’s Response to the… Read More

CPE Launches New Survey on the Role of Brachytherapy in Cancer Care Across Europe

CPE is proud to launch a new survey aimed at raising awareness of the benefits and value of brachytherapy in cancer treatment and improving… Read More

Save the Date: Building Equity, Access, and Sustainability in Cancer Care through an EU Biosimilar Policy and Strategy

CPE, with the support of Medicines for Europe, is pleased to announce a high-level policy event Building Equity, Access, and Sustainability in Cancer Care… Read More

CPE at the iNTERVENE Project Meeting: Advancing Health Literacy and Equity in Cancer Care

On 8–9 October 2025, CPE took part in the iNTERVENE Kick-off meeting in Limassol, Cyprus. The two-day event gathered partners from across Europe to… Read More

CPE at the OECD: Supporting Cancer Patients to Remain and Return to Work

On 8 October 2025, CPE attended the high-level meeting “Building Healthy, Productive Workforces for Our 21st Century” in Paris, hosted by the Organisation for… Read More

CPE Launches Position Paper on Unmet Medical Needs: A Call for a Patient-Centric Definition

CPE is proud to announce the publication of its new Position Paper on Defining Unmet Medical Needs (UMN). This paper comes at a decisive… Read More

CPE Facilitates Interactive Workshop at PREVENT 4th Plenary Meeting in Gorizia

On 22–23 September 2025, PREVENT partners gathered in Gorizia, Italy, for the project’s 4th Plenary Meeting, hosted by ISIG – Istituto di Sociologia Internazionale di Gorizia. The… Read More

CPE Highlights New Lancet Study on the “Right to Be Forgotten” for Young Cancer Survivors

CPE is proud to highlight the publication of an important new study in The Lancet Regional Health – Europe: “5-Year Conditional Relative Survival of… Read More

CPE at the European Parliament: Launching the White Paper on Treatment Optimisation

On 24 September 2025, CPE, together with the European Organisation for Research and Treatment of Cancer (EORTC), launched the White Paper “Embedding Treatment Optimisation… Read More

Predicting Liver Cancer Recurrence After Thermal Ablation: Insights from IMAGIO

Thermal ablation, a minimally invasive procedure that uses heat to destroy cancer cells, is one of the treatments available for hepatocellular carcinoma (HCC), the… Read More

Harnessing Health Records and Genetics to Better Predict Disease Risk

Predicting who may develop certain diseases is a powerful way to improve prevention, diagnosis, and personalised care. Yet, existing models often fall short because… Read More

CPE Launches White Paper on Treatment Optimisation at the European Parliament with EORTC

CPE, with the European Organisation for Research and Treatment of Cancer (EORTC), is proud to announce the launch of the White Paper: “Embedding Treatment… Read More

CPE at the Together4health Conference: Securing Healthcare Sustainability Through Patient and Citizen Empowerment

On September 17th, CPE participated in the Together4health conference, a Danish EU Presidency Conference focused on transforming and integrating healthcare systems and sectors. Hosted… Read More

CPE Workshop on Patient Advocacy: Empowering Researchers to Engage Patients in Cancer Research

On 16 September 2025, CPE hosted a workshop in collaboration with the European Project Marie Curie OncoProTools at the University of Antwerp. The CPE-led… Read More

CPE Joins the SALVOVAR Project

On 11 September 2025, CPE proudly took part in the annual meeting of the EU-funded SALVOVAR project, hosted at IUCT-Oncopole in Toulouse, France.   SALVOVAR… Read More

FUTURE-AI: A Guideline for Trustworthy and Equitable Use of AI in Healthcare

While AI offers transformative potential for healthcare, widespread concerns about trust, fairness, and safety have prevented many AI tools from reaching real-world clinical use.… Read More

Lymphoma: Awareness Can Save Lives

Lymphoma is the most common blood cancer and the third most common childhood cancer. It is estimated that over one million people worldwide are… Read More

Head and Neck Cancer: Awareness Can Save Lives

Head and neck cancers include cancers of the mouth, throat, voice box, nose, and related areas. Together, they make up about 5% of all… Read More

Why Radiotherapy Matters: Closing the Knowledge and Access Gap for Patients

Radiotherapy is one of the cornerstones of modern cancer treatment. More than half of all cancer patients will need it at some stage of… Read More

Highlights from INTERVENE: Building Trust in Medical AI with Patient Perspectives

Artificial intelligence (AI) is rapidly transforming healthcare, offering new possibilities for diagnosis, treatment, and personalised medicine. Yet, as highlighted in a recent cross-project workshop… Read More

Upcoming Event: The New European HTA Regulation – Implications for Patients in Spain

CPE, in collaboration with the Asociación Española Contra el Cáncer (AECC) and Fundació HiTT, is pleased to announce a high-level event taking place at… Read More

CPE at the ECGP Webinar: Unlocking the Potential of Genomic Profiling in Cancer Care

On 9 July 2025, CPE took part in the high-level webinar, “Unlocking the Untapped Potential of Comprehensive Genomic Profiling (CGP): Improving Patient Access and… Read More

CPE at the European Parliament: Putting People at the Heart of Cancer Screening Innovation

On 15 July 2025, CPE spoke at the high-level event “Every Second Counts: Modernising Cancer Screening to Save Lives” at the European Parliament, hosted… Read More

CPE Launches New Survey on the Role of Nutrition in Cancer Care Across Europe

CPE is proud to launch a new survey focused on understanding how cancer-related malnutrition is addressed across different European healthcare systems. This wide-reaching initiative… Read More

CPE at Redcare Pharmacy’s First CDL Session: Designing a Digital, Tailormade, At-Home Future for Pharmacy

On 2 July 2025, CPE took part in Redcare Pharmacy’s inaugural Session in Brussels. The event focused on reimagining the future of pharmacy through… Read More

CPE at UICC Virtual Dialogue: AMR – A Hidden Threat to Cancer Patients’ Lives

On 24 June 2025, CPE took part in the UICC Virtual Dialogue, “The Critical Role of Data in Addressing Antimicrobial Resistance (AMR) for Better… Read More

CPE at the IMAGIO Project Meeting: Advancing Communication and Patient Engagement in Cancer Innovation

On 4–5 June 2025, CPE proudly took part in the annual IMAGIO Consortium Meeting held at Radboud University Medical Center in Nijmegen. IMAGIO is… Read More

CPE at Community 365 Roundtable: Addressing the Silent Threat of Antimicrobial Resistance in Cancer Care

On 27 May 2025, CPE actively participated in the Community 365 Roundtable organised by the European Cancer Organisation (ECO), focusing on the critical question:… Read More

CPE at the 10th Annual World Cancer Series Europe: Strengthening Cancer Control Pathways Across Europe

On 10 and 11 June 2025, CPE participated in the Economist Impact 10th Annual World Cancer Series Europe in Brussels — a leading platform… Read More

CPE at the 8th World Congress on Infectious Diseases: Advocating for Medically Vulnerable Populations in the Post-Pandemic Era

From 9 to 11 June 2025, CPE participated in the 8th Edition of the World Congress on Infectious Diseases, held in Rome, Italy— an… Read More

CPE at LTPC 2025: Catalyzing a National Movement for Equitable Prostate Cancer Care

On 3 June 2025, CPE joined key stakeholders in Rome for the Let’s Talk Prostate Cancer (LTPC) national event, a vital platform to elevate… Read More

CPE at EOSC4Cancer Final Conference: Patients as Co-Creators of the Cancer Data Future

CPE is honoured to be a member of EOSC4Cancer project and, as such, to contribute to the EOSC4Cancer Final Conference held in Barcelona on… Read More

CPE at EuroMedLab 2025: Advocating for Equitable Access to Innovative Cancer Diagnostics

On 21 May 2025, CPE proudly took part in the 26th IFCC-EFLM EuroMedLab Congress in Brussels. Held under the theme “Value of Diagnostics and… Read More

CPE at the first edition of the ROMI network’s conference on BPDCN

On 16 May 2025, CPE participated in the ROMI network’s first Conference dedicated to plasmacytoid dendritic cell (pDC) haematological diseases such as Blastic Plasmacytoid… Read More

CPE Joins the INSPIRE Project

On 15–16 May 2025, CPE proudly took part in the annual meeting of the EU-funded INSPIRE project in Aarhus, Denmark. INSPIRE is a research… Read More

CPE at the Multidisciplinary Cancer Forum: Championing Patient-Centred Innovation in Radiotherapy

On 2 May 2025, CPE was honoured to take part in the “Multidisciplinary Cancer Forum -Unlocking a New Era in Cancer Treatment”, held at… Read More

CPE at ESMO Breast Cancer 2025: Bridging Gaps in Awareness and Access to Personalised Care

On 15 May 2025, CPE joined ESMO Breast Cancer 2025 Conference in Munich, a major event dedicated to the latest advancements in breast cancer… Read More

CPE Endorses German biobanks Node Position Paper

CPE is proud to endorse a newly released position paper by German Biobank Node (GBN) calling for long-term support of academic biobanks and greater… Read More

CPE at MedTech Forum 2025: Advancing Innovation and Equity in Cancer Care

On 14 May 2025, CPE participated in the MedTech Forum 2025 in Lisbon, Europe’s leading event on medical technology, organised by MedTech Europe. The… Read More

CPE at ESTRO 2025: Advocating for Patient-Centred Access to Brachytherapy

On 2 May 2025, CPE participated in the ESTRO 2025 Conference in Vienna. Organised under the theme “Shaping the Future of Brachytherapy: A Roadmap… Read More

CPE at the Precision Oncology Forum: Advancing Patient-Centred Innovation in mBC Diagnostics

On 28 April 2025, CPE took part in the Precision Oncology Forum in Stockholm organised by Precision Medicine Forum. The forum highlighted emerging tools… Read More

Launch of the joint Call to Action “5 Ways to Reduce Cancer Care Inequalities in Europe”

On Tuesday 23rd April 2025, CPE launched the joint Call to Action “5 Ways to Reduce Cancer Care Inequalities in Europe” at the European… Read More

CPE at the Cell & Gene Meeting on the Med 2025

On 15 April 2025, CPE was proud to take part in the 2025 Cell & Gene Meeting on the Med, hosted in Rome by… Read More

CPE at ESCMID Global 2025: Shining a Light on AMR’s Impact on Cancer Patients

On 14 April 2025, CPE took part in ESCMID Global 2025 in Vienna, hosted by the European Society of Clinical Microbiology and Infectious Diseases.… Read More

CPE at the EAEP General Assembly 2025: Championing Digital Health and Access to Medicines

On 10 April 2025, CPE took part in the General Assembly of the European Alliance for Ethical and Sustainable Access to Medicines (EAEP), held… Read More

CPE Launches New Survey on the Benefits and Value of Combination Therapies for Cancer Patients

CPE is excited to announce the launch of our new survey aimed at cancer patients from all types of cancer diagnoses. This comprehensive survey is… Read More

CPE Joins High-Level AMR Discussions at the European Parliament “Untreatable Infections – Meeting the Threat to Safeguard the Future of Healthcare in Europe”

CPE joined the high-level meeting at the European Parliament for “Untreatable Infections – Meeting the Threat to Safeguard the Future of Healthcare in Europe”.… Read More

CPE at the 2025 Biosimilar Medicines Conference

On 3rd April 2025, CPE participated in a high-level panel discussion about the transformative potential of biosimilars in improving cancer care across Europe and… Read More

CPE at the EAA Spring Convention: Shaping the Future of EU HTA Performance Measurement

On 3rd April 2025, Cancer Patients Europe (CPE) actively contributed to the European Access Academy (EAA) Spring Convention in Berlin, a key event addressing… Read More

Launch Event: “5 Ways to Reduce Cancer Care Inequalities in Europe” Call to Action

Cancer Patients Europe (CPE) is organising a high-level event at the European Parliament (SPINELLI A5F385) on 23rd April 2025, from 16:00 to 17:30 CEST.… Read More

CPE at the INTERVENE Annual Meeting 2025: Advancing Genomic Research for Personalised Healthcare

On 27-28 March 2025, Cancer Patients Europe (CPE) with its Project Officer Kaustubh Dhurandhar participated in the INTERVENE Annual Meeting in Turin, Italy. Organised… Read More

CPE at EAVH Webinar: A Call for Collaboration in Value-Based Healthcare

On 26 March 2025, Cancer Patients Europe (CPE) participated in the European Alliance for Value in Health (EAVH) webinar titled "A Compass for Collaboration:… Read More

CPE at the GLIOMATCH Consortium Meeting: Addressing Inequality in Cancer Research

CPE's Research and Patient Engagement Director Juan Jose Ventura and Communications Officer Chiara Zampolli participated in the GLIOMATCH 3rd Consortium Meeting in Düsseldorf from 25th to 26th March… Read More

CPE at the European Parliament: Addressing Inequalities in Access to Innovative Medicines

On 25 March 2025, CPE participated in the high-level event “Innovative Medicines Not for Small Member States?”, hosted at the European Parliament. The discussion with… Read More

CPE at the European Parliament: Advancing Equitable Access to Medicines Through Digital Innovation

On 20 March 2025, CPE participated in the high-level event “Equitable Access to Medicines Across Europe: The Role of Digital Solutions”, held at the European… Read More

Six months progress of Mission Early: Key achievements and highlights

Today, 18th of March 2025, marks six months since the official launch of Mission Early, a global initiative dedicated to advancing early cancer detection… Read More

Ensuring Access to Innovative Cancer Treatments: Key Takeaways from the HTA Event in Italy

On March 13, 2025, CPE and Rete Oncologica Pazienti Italia (ROPI) successfully hosted the event “Access to Medicines for Cancer Patients: Italy’s Response to the New… Read More

Awareness of Genomic Testing Among Patients with Breast Cancer in Europe- myC Initiative

Genomic testing is transforming cancer care by enabling personalised treatment approaches. As part of the myC (my Cancer my Concern) Initiative, CPE conducted a… Read More

CPE Hosts an HTA Event in Italy: Preparing for the Future of Health Technology Assessment

Cancer Patients Europe (CPE), in collaboration with ROPI (Rete Oncologica Pazienti Italia) a local partner, has organized an event on HTA in Italy, a… Read More

Cancer Patients Europe Joins the 2025 Global Forum as a Supporting Partner

CPE is delighted to announce its role as a Supporting Partner for the 2025 Global Forum: Creating Health Through Understanding and Personalising Value, taking place on 4th… Read More

CPE Calls for an Inclusive and Transparent Implementation of the European Health Data Space

With the European Health Data Space (EHDS) regulation now officially published, Cancer Patients Europe (CPE) joins a coalition of 39 leading health stakeholders in… Read More

Healthier Europe: Opening ceremony of Health Union Fellowship

CPE was invited to attend the launch of the inaugural Health Union Fellowship took place on 10th February at The College of Europe in… Read More

Event at European Parliament on Equitable Access to Medicines Across Europe: The Role of Digital Solutions

Cancer Patients Europe (CPE) is pleased to support the OnHOME Alliance in hosting the event “Equitable Access to Medicines Across Europe: The Role of… Read More

CPE Attends Clinical Trials Innovation Programme in Nice

On the 11th of February , Antonella Cardone, CEO of Cancer Patients Europe (CPE), took part in a panel discussion on "Patient Safety: Toward… Read More

CPE Hosts European Semester on Health Event

On Thursday 6th of February Cancer Patients Europe (CPE), in collaboration with the office of MEP Vlad Voiculescu (RENEW), held an event at the… Read More

CPE Launches White Paper on ESR1 Mutations and Liquid Biopsy in Metastatic Breast Cancer at the European Parliament

This last 29th of January, Cancer Patients Europe (CPE) launched their new White Paper on ESR1 Mutations and Liquid Biopsy in Metastatic Breast Cancer… Read More

CPE Joins OASIS!

Cancer Patients Europe (CPE) is proud to announce its participation in OASIS, a new European research programme dedicated to optimising antibody-drug conjugates (ADCs) for… Read More

Your Voice Counts: Participate in the ASCERTAIN Project Survey

Cancer Patients Europe (CPE) is glad to support the ASCERTAIN project, an initiative focused on developing accessible tools for pricing, value assessment, and reimbursement of… Read More

Launch of White Paper on ESR1 Mutation and Liquid Biopsy in Metastatic Breast Cancer at the European Parliament

Cancer Patients Europe (CPE), in collaboration with MEPs Nikos Papandreou (S&D), Vlad Voiculescu (RENEW), and Loucas Fourlas (EPP),  will host an event at the European… Read More

EU Semester on Health: Building Momentum – A tool to reduce health inequalities across Europe

Cancer Patients Europe (CPE) and CECOG are excited to share our Save the Date for an upcoming event at the European Parliament, scheduled for… Read More

New White Paper Released: COVID-19 Policy and Disease Management Recommendations for the Post-Pandemic Era

This white paper, developed by a group of health experts and advocates, explores the evolving landscape of COVID-19 management in the post-pandemic era. It… Read More

IMAGIO Achieves Key Milestone in Multimodal Ablation Therapy for Liver Cancer Clinical Trials

IMAGIO is pleased to announce the enrolment of its first patient at the Istituto Tumori in Italy, marking a significant milestone in advancing multimodal… Read More

Webinar on The Price of Success: Can innovative payment models support access to combination therapies in Europe?

On 5 December, the webinar on “The Price of Success: Can Innovative Payment Models Support Access to Combination Therapies in Europe?” hosted by the… Read More

Shared Decision-Making in Breast Cancer Advisory Board meeting

The Genomics Network Meeting, organised by Exact Sciences, brought together healthcare professionals (HCPs), patient advocates, and organisations to discuss strategies for improving Shared Decision-Making… Read More

Advancing Understanding on BPDCN Through Patient Knowledge Empowerement

On 9th December 2024, Cancer Patients Europe (CPE) hosted a webinar titled "Advancing Understanding on BPDCN: Empowering Patients Through Knowledge." The event sought to raise… Read More

Navigating a Changing Cancer Care System: Insights from the Sixth Annual European Cancer Forum

The Sixth Annual European Cancer Forum, themed "Implementing a Sustainable Future for Cancer Care," took place on December 4, 2024, in Brussels. Cancer Patients… Read More

Webinar – Advancing Understanding on BPDCN: Empowering Patients Through Knowledge

We at Cancer Patients Europe (CPE) are dedicated to empowering patients with knowledge and support, especially those facing rare and challenging conditions. That is… Read More

CPE CEO Addresses Patient Diversity and Trust in Real-World Data at Real4Reg Workshop

The Real4Reg workshop, titled "Demystifying Real-World Data - Insights for Patients", convened online on October 14th, 2024, to explore the potential of real-world data (RWD) in regulatory… Read More

CPE’s Josephine Mosset Champions Patient Voice in EU HTA Regulation at Access EU 2024

Between the 14th and 16th of November, CPE’s Policy Officer Josephine Mosset, attended the Access EU 2024 conference in Barcelona, themed on "Addressing challenges… Read More

CPE Advocates for Patient-Centric Approach at COG (Clinical Outsourcing Group) Europe 2024

The second annual Clinical Outsourcing Group (COG) Europe 2024 conference in Amsterdam, held on November 13th, brought together key players in clinical research to… Read More

CPE Engages with MEPs on Key Cancer Care Issues

Over the last months, following the results of the European Elections, we at Cancer Patients Europe have been actively engaging and meeting with both… Read More

Early Cancer Care: CPE Pushes for Stronger EU Action 

On November 19th, Cancer Patients Europe (CPE) CEO Antonella Cardone participated in Mission Early’s EU Policy Roundtable. The discussion centred on advancing policy change… Read More

Cancer and AMR: A Shared Crisis That Calls for Urgent Action

This week marked World Antimicrobial Resistance (AMR) Awareness Week, a vital moment to shed light on a health crisis that threatens millions of lives… Read More

Cancer Patients Europe congratulates Olivér Várhelyi on his appointment as European Commissioner for Health and Animal Welfare

Cancer Patients Europe congratulates Olivér Várhelyi on his appointment as European Commissioner for Health and Animal Welfare. As he assumes this critical role, we… Read More

CPE Tackles Liver Cancer at ELPA Policy Event

Prioritising Liver Health in EU Policy CPE had the honour of participating in the European Liver Patients' Association (ELPA)’s high level policy event "The… Read More

POLITICO Health Care Summit 2024

The EU Beating Cancer Plan has driven progress across the cancer care pathway, and towards reducing health inequities, yet challenges like clinical trial competitiveness,… Read More

Advancing the Precision Oncology Agenda in the EU-Event Highlights

At the recent “Advancing the Precision Oncology Agenda in the EU” event held on the 13th of November 2024, key stakeholders gathered at the… Read More

Advancing Patient-Centered Care: Insights from EU-Africa PerMed and FT3 on Personalised Medicine

On 29 October 2024, the EU-Africa PerMed consortium, in collaboration with From Testing to Targeted Treatments (FT3), hosted the 10th EU-Africa PerMed Webinar titled… Read More

CPE Responds to the European Commission’s Consultation on the EU HTA Regulation’s Joint Scientific Consultations

The European Union has adopted its Regulation on Health Technology Assessment (HTA) which will come into force by next January 2025 for oncology products and advanced therapy medicinal products… Read More

Breaking Barriers in Clinical Trials: Highlights from the Act EU Multi-Stakeholder Platform Annual Meeting

On October 22, 2024, clinical trial experts, regulators, and patient advocates from across Europe convened at the European Medicines Agency (EMA) headquarters in Amsterdam… Read More

A few words from Violeta Pirana on how Renesansa is Empowering Women Affected by Breast Cancer in Kosovo

October or “Pink October” is globally renowned as Breast Cancer Awareness Month, an important time dedicated to increasing understanding of a disease that ranks… Read More

CPE’s Policy Officer Speaks About the EU HTA Regulation Implementation and Explains What This Means for Patients.

With the upcoming implementation of the EU Health Technology Assessment Regulation (HTAR) in January 2024, Europe is set to witness significant shifts in how… Read More

The Need for Ongoing Focus on Liver Cancer Awareness: An Interview with Beatrice Credi, Head of ELPA’s Brussels Office

Raising awareness about liver cancer is crucial, as it is the third leading cause of cancer-related deaths worldwide. Often referred to as a silent… Read More

Highlights from the European Commission’s Conference on Innovative Palliative Care for Cancer Patients

CPE’s Policy Officer Josephine Mosset and Communications Officers Kaustubh Dhurandhar and Joana Kokalari participated in the European Commission’s conference on Innovative Palliative Care, which… Read More

SAMPSPGS 7th Congress: The Power of Prevention

The 7th Congress SAMPSPGS of the Andalusian Society of Preventive Medicine, Public Health, and Health Management took place in Huelva, Spain on September 26-27,… Read More

CPE at the EUPATI AGM 2024

CPE was delighted to participate in the second day of the EUPATI Annual General Meeting (AGM) 2024, where we engaged in a pivotal workshop… Read More

Uniting Europe Against Cancer: The Push for a European Semester on Health

Tuesday, 24 September 2024 at the European Health Forum Gastein "A European Semester on Health?" This pivotal question set the tone for a session… Read More

Call to Action on EU Joint Clinical Assessment for ATMPs: Current Status

In July 2024, CPE, together with The Alliance for Regenerative Medicine (ARM) and Fondazione Telethon, issued a joint call to action on the EU’s… Read More

Childhood Cancer Awareness Month: A few words from Anita Granero

Every year, during Childhood Cancer Awareness Month, we are reminded of the significant impact that childhood cancer has on children, their families, and the… Read More

Webinar – Upcoming Health Technology Assessment Regulation (HTAR)

We are now at the last of our engaging webinar series, organised to equip cancer patients ahead of the European Commission’s Info Days focusing… Read More

September: A Month to Raise Awareness on Gynaecological Cancers

Every September marks Gynaecological Cancer Awareness Month, a month that highlights a series of cancers that often go unnoticed but affect thousands of women… Read More

Key Considerations From CPE on the EU-HTA-Regulation

Starting January 2025, a new European Union regulation, the Health Technology Assessment (HTA), will change how decisions are made regarding the coverage of new… Read More

Francisco Rodriguez Lozano Honored with WHO Award for Tobacco Control: Insights from La Provincia

In a recent feature by La Provincia newspaper, Francisco Rodriguez Lozano, Chair of Cancer Patients Europe (CPE), shared his insights on the global fight… Read More

CPE joins the EU-X-CT initiative

We are pleased to announce that Cancer Patients Europe (CPE) has joined the EU-X-CT initiative, a pan-European multistakeholder endeavour, co-led by the European Federation… Read More

CPE and MNI Join Forces

CPE and the Medical Nutrition International Industry (MNI) have joined forces on an initiative aimed at addressing the significant yet often overlooked nutritional challenges… Read More

CPE joins the IMAGIO Project

We are thrilled to announce that Cancer Patients Europe (CPE) has joined the groundbreaking IMAGIO project, a large EU-funded project focusing on advancing interventional… Read More

CPE holds its 2024 General Assembly Meeting

On July 18, 2024, CPE members convened for the Annual General Assembly Meeting. This was the second AGM since the organisation’s inception and marked… Read More

CPE Joins OnHOME Alliance

We are excited to announce that CPE has officially joined the Online Order and Home Delivery of Medicines Alliance (OnHOME). This partnership is a… Read More

Webinar – Plain Language Summaries to Support Patient Expert Input to HTA: Lessons and guidance for Patient Organisations, HTA Bodies and Industry

CPE’s CEO Antonella Cardone will be speaking at the upcoming webinar, "Plain Language Summaries to Support Patient Expert Input to HTA: Lessons and Guidance… Read More

“Getting Our Act Together”: Multistakeholder Meeting on Access to Therapy for Pancreatic Cancer

On 25 June 2024, Pancreatic Cancer Europe (PCE) organized the "Getting Our Act Together" Multistakeholder Meeting on Access to Therapy for Pancreatic Cancer in… Read More

Webinar – Upcoming Health Technology Assessment Regulation (HTAR)

CPE is hosting its third webinar on the upcoming Health Technology Assessment Regulation (HTAR) on the 28th of August 2024, 17:00 - 18:30 CEST.… Read More

CPE Responds to the European Commission’s Consultation

The European Union has adopted its Regulation on Health Technology Assessment (HTA) which will come into force by next January 2025 for oncology products… Read More

Highlights from the QUALITOP End-of-Project Conference and Workshop

On the 26th and 27th of June, CPE and 13 partners from the QUALITOP consortium, gathered in Amsterdam for an event focusing on the advancements… Read More

Concerned Stakeholders Issue Call to Action on the Implementation of the EU Joint Clinical Assessment for ATMPs

Brussels, BE – 10 July, 2024 Without methodologies suited to ATMPs, the JCA will create a new barrier to patient access The new EU… Read More

Roundtable on Creating a European network of pancreatic cancer registries – Results from the PancreOS Project

On Thursday, 27 June in Santiago de Compostela, Spain, stakeholders from different fields gathered to discuss the findings of the PancreOS Project, a Pancreatic… Read More

PREVENT’s Third Plenary Meeting

CPE’s Policy Officer Josephine Mosset and the Communications Officers, Joana Kokalari and Tristan Hanssen, traveled to Stockholm, Sweden for the third plenary meeting of… Read More

10 Key Recommendations for Enhancing Joint Clinical Assessments Under the EU HTA Regulation

CPE together with leading patient organisations across Europe has come together to release a set of ten key recommendations aimed at improving patient involvement… Read More

QUALITOP Workshop & Conference to be Hosted in Amsterdam

The consortium of the QUALITOP project, of which CPE is a proud member, is thrilled to announce an upcoming Workshop and Conference, set to… Read More

CPE and GAMIAN-Europe release the “Empower and Connect” Toolkit to increase awareness on cancer and depression

The emotional and psychological toll of a cancer diagnosis can be as challenging as the physical aspects of the disease. Cancer patients are often… Read More

CPE’s Chair of the Board Receives Prestigious Award on World No Tobacco Day 2024

The 2024 WNTD Awards CPE is thrilled to announce that our Chair of the Board, Francisco Lozano, has been honoured by the WHO with… Read More

“5 Ways to Reduce Cancer Care Inequalities in Europe: Looking Beyond the Elections”

As part of this year’s European Week Against Cancer (EWAC), we are launching a series of mini-webinars titled “5 Ways to Reduce Cancer Care… Read More

Position Paper on Pancreatic Cancer Across Europe in Light of the 2024 EU Elections

May 15, 2024 CPE is pleased to announce our latest position paper addressing the critical issue of pancreatic cancer across Europe in light of… Read More

Biosimilars in Cancer Care: Ensuring Patient Empowerment and Accessibility

Biosimilars in Oncology As the healthcare landscape evolves at an unprecedented pace, awareness and understanding become paramount for patients navigating various treatment and care… Read More

Continuous support for the Cancer Inequalities Manifesto: Every Signature a Step Closer to Our Target

Exciting developments unfolded on the 11th of April at the European Parliament as our CEO, Antonella Cardone, and María Teresa Deus Trasobares, President of ASARGA… Read More

Second European Parliament Roundtable Addresses Urgent Needs in Lung Cancer Care

Brussels, 9 April 2024 – Together with stakeholders from the Swedish Institute of Health Economics, the European Lung Cancer Association, and MSD, CPE co-organised… Read More

“World Health Day 2024: Time to Move from Awareness to Action”

This year’s World Health Day, themed 'My health, my right' reminds us of the global challenges we face, from diseases and disasters to conflicts… Read More

Interactive Workshop: Sharing Insights on Navigating Cancer and Depression

CPE is happy to support GAMIAN-Europe, in the organisation of an interactive online workshop on Thursday, 11th of April from 14:00-16:00 (CEST). The workshop… Read More

CPE JOINS QUALITOP

Cancer Patients Europe (CPE) has recently joined the consortium of Qualitop, marking a significant step forward in improving the quality of life for cancer… Read More

GLIOMATCH project kick-off meeting

We were thrilled to take part in the GLIOMATCH kick-off meeting, which took place on March 25 and 27, 2024, in Leuven, Belgium. This… Read More

3rd OPMDay Annual Congress

CPE is co-organising the OPMDay Annual Congress, a two-day conference dedicated to exploring Oral Potentially Malignant Disorders (OPMDs). The event, hosted by Prof. Rui… Read More

Interceptor Working Group Meeting and Workshop

CPE will take part in the two-day working group meeting and workshop that is set for April 29 and 30, 2024, in Milan, Italy,… Read More

EP Roundtable on “Fighting Lung Cancer Together as Equals – A Year On”

CPE is proud to support the organisation of this second roundtable at the European Parliament. Following the first gathering held in October 2022, marked… Read More

Vibrant discussions at the Spanish Ministry of Health

The Spanish tobacco control unit and experts convened in Madrid on the 22nd of March, to revise the tobacco control law. During this high-level… Read More

CPE Launches New Patient Survey on Metastatic Breast Cancer Biomarkers

Cancer Patients Europe (CPE) is proud to announce the launch of our new patient survey aimed at patients who have been diagnosed with metastatic… Read More

CPE’s second webinar on the upcoming Health Technology Assessment Regulation (HTAR)

CPE is hosting its second webinar on the upcoming Health Technology Assessment Regulation (HTAR) on the 2nd of April,2024, 17:00 - 18:30 CEST. The… Read More

Enhancing Stakeholder Engagement in the European Health Technology Assessment (HTA) Process: Insights from New Research

We are excited to announce the publication of a research paper shedding light on the role of stakeholder involvement in the European Health Technology… Read More

PREVENT releases its official brochure

The PREVENT project, funded by the Horizon Europe programme of the European Union, has unveiled its official brochure, delving into the global impact of… Read More

8th March International Women’s Day

In a tribute to the strength and resilience of women worldwide, today marks a celebration of their indomitable spirit. A special acknowledgment goes out… Read More

Ending Financial Discrimination Against Cancer Survivors

Our CEO Antonella Cardone took the stage at the High-Level Conference on Ending Financial Discrimination Against Cancer Survivors, led by Dr Françoise Meunier on… Read More

CPE and EONS sign Memorandum of Understanding (MoU)

CPE and the European Oncology Nursing Society (EONS) have signed a Memorandum of Understanding (MoU) to establish a framework for collaboration and mutual support… Read More

Francisco Lozano’s speech at the Parliament of the Canary Islands

The inaugural for the first "Week Against Cancer" awareness raising event, was organised on the 6th of February, at the Parliament of the Canary… Read More

The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European healthcare ecosystem

26 February 2024 – Cancer Patients Europe (CPE), as part of a coalition of 35 large health stakeholder organisations representing patients, health professionals, researchers,… Read More

Cancer Momentum: Fighting Cancer Inequalities in the EU Event at the European Parliament

On Wednesday, February 14th, Cancer Patients Europe (CPE) and the Central European Cooperative Oncology Group (CECOG), in collaboration with Members of the European Parliament… Read More

“The Cancer Momentum: Fighting Inequalities in Europe”

CPE is proud to organise its 1st event at the European Parliament Cancer mortality varies widely across Europe, and survival depends on where you… Read More

Consensus Conference on Larynx Preservation for Laryngeal/Hypopharyngeal Squamous Cell Carcinoma

Milano, 12/04/2024 Ore 9  Registrations of participants 09:30 Opening of the congress 09:50- 10:20 Introduction: Presentation of the project  10:20 - 10:50 Session 1… Read More

Stakeholder coalition calls for legislative refinement of the EHDS

4 December 2023, Brussels – Cancer Patients Europe, as part of a large multi-stakeholder group, representing the entire spectrum of the healthcare ecosystem and… Read More

Transforming EU Continence Health: A Manifesto for Policy Reform

On 8 November CPE joined 22 scientific, professional, patient and non-profit organisations in launching a manifesto for policy reform on Continence Health in Europe.… Read More

Awareness of Genomic Testing in Breast Cancer – A Call to Action Across Europe

Awareness of Genomic Testing in Breast Cancer Awareness of Genomic Testing in Breast Cancer – A Call to Action Across Europe Cancer Patients Europe is… Read More

Patient Leadership to Tackle Cancer in Europe. Cancer Patients Europe’s event

Cancer Patients Europe had the pleasure of hosting the first event on Patient Leadership to tackle Cancer in Europe and presenting CPE's mission to… Read More

Oral Potentially Malignant Disorders, August 31th-31st Antwerp, Belgium Abstract call by July 4th

The first face-to-face OPMDay is on August 30th-31st in Antwerp, Belgium. The 2023 meeting focuses on the clinical and pathological diagnosis, biomarker and biological… Read More

“We won’t recover from a missed opportunity”

From Europe's Beating Cancer Plan to the new HTA Regulation: our CEO Antonella Cardone discusses Cancer Patients Europe's mission and policy priorities answering questions… Read More

Gaps in breast cancer care in Europe and the Importance of genomic testing

The my Cancer my Concern initiative has highlighted the gap in genomic testing awareness. Cancer Patients Europe and Exact Sciences discuss it with pharmaphorum.com Read… Read More

Participate now in the ThermoBreast Survey

Does a mammogram hurt? Will a biopsy scar be noticeable? How often should I get a breast cancer screening? The EU-funded project ThermoBreast is… Read More

Joint Statement: health organisations define EHDS’ opt out required for life saving research

On 6 June, Cancer Patients Europe joined together with 31 other health stakeholders to share views on specific recommendations for a potential opt-out mechanism… Read More

The European Health Technology Assessment Regulation: The Political Will

On 28 February 2023, Pancreatic Cancer Europe (PCE) and Cancer Patients Europe (CPE) held a webinar to exchange views on how best to enhance cooperation on the HTA process… Read More

myCancer myConcern infographics

Find here infographics of the topline country results (in English) about the myCancer myConcern initiative. Feel free to email us requesting the documents in… Read More

Better Decision-Making for Better Outcomes: a Call to Action on Harnessing the Power of Real-World Evidence

Recent years have seen growing recognition of the role that data can play in enabling not only better health system performance, but also better… Read More

Better Decision-Making for Better Outcomes: Harnessing the Power of Real-World Evidence

Join our CEO Antonella Cardone at the expert roundtable hosted by MEP Stelios Kympouropoulos at the European Parliament and discuss how real-world data can… Read More

Incontinence and Mental Health. Call for Evidence on a Comprehensive Approach to Mental Health

In the 2022 State of the European Union address, European Commission President von den Leyen announced a new European Mental Health Strategy. As a… Read More

Webinar – The European Health Technology Assessment Regulation: the political will

In order to support the development or strengthening the cooperation among all relevant stakeholders and better understand the role that patients can play in the process… Read More

myC: first European-wide patient survey in genomic testing in breast cancer

On the 17th of November 2022, CPE launched the results of the first European-wide patient survey in genomic testing in breast cancer. 4 out… Read More